Our Work

Sort By

The Time Has Come: Adjunct Therapies for Type 1 Diabetes

Given that T1D patients share many of the same comorbidities as T2D patients, doctors have been prescribing them to T1D patients ‘off label’.

Abstract Published at European Association for the Study of Diabetes (EASD) Annual Meeting

dQ&A is excited to share…

T2 Insulin Insights Data Service

T2 Insulin Insights is a unique semi-annual Research Service…

Major Grocery Chains Failing to Meet the Needs of People With Diabetes

We are excited about the highly anticipated…

Donating to Spare a Rose for Ukraine

In our most recent survey, we gave our community…

Announcing dQ&A’s First Look Insights Qualitative Research Service

We are excited about the highly anticipated…

dQ&A® Psychographics White Paper

We’ve conducted a rigorous psychographic categorization…

New dQ&A® Data on COVID-19 Booster Status in People with Diabetes

Booster rates are significantly higher for…

FDA Advisory Committee: dQ&A® Panel Members Weigh in on Provention Bio’s Teplizumab

The FDA decided in a 10:7 vote…